Bifogade filer
PDF
Kurs & Likviditet
Beskrivning
| Land | Sverige |
|---|---|
| Lista | Large Cap Stockholm |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
"We start the year with growth and improved profitability. Rental and service develop well globally and the positive trend in the US continues, with a gradual improvement of the market situation. Overall, a solid start to the year and I look forward to continue the work together with the team to strengthen Arjo's positions in 2024," says Joacim Lindoff, President and CEO of Arjo.
January-March 2024 in brief- Net sales increased to SEK 2,759 M (2,638).
- Adjusted EBITDA increased 5.7% to SEK 502 M (475).
- Adjusted operating profit increased 13.2% to SEK 248 M (219).
- Profit after financial items increased to SEK 175 M (150).
- Earnings per share rose to SEK 0.48 (0.42).
- Cash flow from operations rose to SEK 256 M (250), corresponding to a cash conversion of 54.2% (54.5).
- Arjo's climate targets were approved by the Science Based Targets initiative during the quarter.
Telephone conference
Fund managers, analysts and media are invited to participate in a conference call and presentation of the report on April 18 at 15:00 CEST via the following link: https://ir.financialhearings.com/arjo-q1-report-2024
Those who wish to ask questions verbally during the teleconference will need to register via the link below. A phone number and a conference ID will be provided after registration in order to access the conference. Link to registration: https://conference.financialhearings.com/teleconference/?id=50048573
Alternatively, use the following link to download the presentation:
https://www.arjo.com/int/about-us/investors/reports--presentations/2024/
A recorded version of the conference is accessible for three years via the following link:
https://ir.financialhearings.com/arjo-q1-report-2024
For more information, please contact:
Maria Nilsson, EVP Communications & Public Relations
Tel: +46 734 244 515
Email: maria.nilsson@arjo.com
Sara Ehinger, VP Investor Relations & Corporate Communications
Tel: +46 723 597 794
Email: sara.ehinger@arjo.com
This information is information that Arjo AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 14:00 CEST on April 18, 2024.
About Arjo
At Arjo, we believe that empowering movement within healthcare environments is essential to quality care. Our products and solutions are designed to promote a safe and dignified experience through patient handling, medical beds, personal hygiene, disinfection, diagnostics, and the prevention of pressure injuries and venous thromboembolism. With more than 6,500 people worldwide and over 65 years caring for patients and healthcare professionals, we are committed to driving healthier outcomes for people facing mobility challenges. www.arjo.com